CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 119 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $584,000 | -62.5% | 197,888 | -60.4% | 0.15% | -23.3% |
Q1 2022 | $1,556,000 | +84.1% | 500,000 | +100.0% | 0.19% | +55.6% |
Q4 2021 | $845,000 | +482.8% | 250,000 | +886.6% | 0.12% | +327.6% |
Q4 2020 | $145,000 | -25.3% | 25,339 | +69.7% | 0.03% | -37.0% |
Q1 2018 | $194,000 | -37.6% | 14,933 | -55.8% | 0.05% | -35.2% |
Q4 2017 | $311,000 | – | 33,797 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |